Myocardial intramural course may reduce left ventricular ejection fraction of patients suffering from coronary heart

Shi Miaomiao1, Zheng Jiaqi2, Li Xiaomeng1

  • 1Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China.

Insights

Myocardial intramural course (MIC) may reduce cardiac function in coronary heart disease (CHD) patients. This anatomical variation is linked to lower left ventricular ejection fraction (LVEF), especially with increased stenosis.

Area of Science:

  • Cardiology
  • Anatomical Pathology
  • Cardiac Function Assessment

Background:

  • Myocardial intramural course (MIC) is an abnormal blood vessel routing.
  • MIC is increasingly associated with coronary heart disease (CHD).
  • The impact of MIC on cardiac function in CHD patients is not well understood.

Purpose of the Study:

  • To investigate the association between MIC and cardiac function in patients with CHD.
  • To determine if MIC contributes to impaired cardiac function in CHD patients.

Main Methods:

  • 126 patients with MIC were identified via coronary angiography and/or CT angiography.
  • 39 patients with both MIC and CHD formed the MIC-CHD group.
  • 60 CHD patients without MIC served as the control group.

Main Results:

  • Left ventricular ejection fraction (LVEF) was significantly lower in the MIC-CHD group (0.62) compared to the CHD group (0.67).
  • LVEF showed a negative correlation with the degree of systolic stenosis in mural coronary arteries (MCAs).
  • LVEF also demonstrated a negative correlation with the length of the MIC.

Conclusions:

  • MIC in conjunction with CHD may lead to reduced LVEF.
  • MIC length and MCA stenosis severity are negatively associated with LVEF in these patients.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
16.0K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
647
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
344
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761